Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 195-205

  Kim, Cheol Su ^a   Nguyen, Hai Duong ^a   Ignacio, Rosa Mistica ^a   Kim, Jae Hyun ^a   Cho, Hyeon Cheol ^a   Maeng, Eun Ho ^b   Kim, Yu Ri ^c   Kim, Meyoung Kon ^c   Park, Bae Keun ^a   Kim, Soo Ki ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Korea Testing and Research Institute   (South Korea)

^c Korea University   (South Korea)

Author keywords

Cytokine; Cytotoxicity; Immune response; Immunosuppression; Innate immunity; ZnO

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; ZINC OXIDE NANOPARTICLE; CYTOKINE; METAL NANOPARTICLE; ZINC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4 CD8 RATIO; CELL VIABILITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG CYTOTOXICITY; IMMUNOPHENOTYPING; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARTICLE SIZE; SPLEEN CELL; STATIC ELECTRICITY; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; TOXICITY TESTING;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOKINES; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; PARTICLE SIZE; STATIC ELECTRICITY; TOXICITY TESTS; ZINC OXIDE;

EID: 84930505948     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57935     Document Type: Article

References (49)

1. Duguet E, Vasseur S, Mornet S, Devoisselle JM. Magnetic nanoparticles and their applications in medicine. Nanomedicine (Lond). 2006;1(2): 157-168.
2. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004;2(1):3.
3. Sanvicens N, Marco MP. Multifunctional nanoparticles – properties and prospects for their use in human medicine. Trends Biotechnol. 2008;26(8):425-433.
4. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761-769.
5. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-149.
6. Hanley C, Layne J, Punnoose A, et al. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology. 2008;19(29):295103.
7. Zhang H, Chen B, Jiang H, Wang C, Wang H, Wang X. A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials. 2011;32(7):1906-1914.
8. Hooper HL, Jurkschat K, Morgan AJ, et al. Comparative chronic toxicity of nanoparticulate and ionic zinc to the earthworm Eisenia veneta in a soil matrix. Environ Int. 2011;37(6):1111-1117.
9. Jang J, Lim DH, Choi IH. The impact of nanomaterials in immune system. Immune Netw. 2010;10(3):85-91.
10. Matsumura M, Takasu N, Nagata M, Nakamura K, Kawai M, Yoshino S. Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice. J Immunotoxicol. 2010;7(3):232-237.
11. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health. 2012;28(8):675-686.
12. Zheng YF, Li Z, Wang YD. In vitro and in vivo biocompatibility studies of Zno nanoparticles. Int J Mod Phys B. 2009;23(06-07):1566-1571.
13. Bae HC, Ryu HJ, Jeong SH, et al. Oxidative stress and apoptosis induced by ZnO nanoparticles in HaCaT cells. Mol Cell Toxicol. 2012;7(4):333-337.
14. Lee SH, Pie J-E, Kim Y-R, Lee HR, Son SW, Kim M-K. Effects of zinc oxide nanoparticles on gene expression profile in human keratinocytes. Mol Cellular Toxicol. 2012;8(2):113-118.
15. Heng BC, Zhao X, Tan EC, et al. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol. 2011;85(12):1517-1528.
16. Roy R, Tripathi A, Das M, Dwivedi PD. Cytotoxicity and uptake of zinc oxide nanoparticles leading to enhanced inflammatory cytokines levels in murine macrophages: comparison with bulk zinc oxide. J Biomed Nanotechnol. 2011;7(1):110-111.
17. Yanagisawa R, Takano H, Inoue K, et al. Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med (Maywood). 2009;234(3):314-322.
18. Liu Y, Jiao F, Qiu Y, et al. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials. 2009;30(23-24):3934-3945.
19. Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009;4(12): 1409-1420.
20. Heng BC, Zhao X, Xiong S, Ng KW, Boey FY, Loo JS. Toxicity of zinc oxide (ZnO) nanoparticles on human bronchial epithelial cells (BEAS-2B) is accentuated by oxidative stress. Food Chem Toxicol. 2010;48(6):1762-1766.
21. Lipovsky A, Nitzan Y, Gedanken A, Lubart R. Antifungal activity of ZnO nanoparticles - the role of ROS mediated cell injury. Nanotechnology. 2011;22(10):105101.
22. Song W, Zhang J, Guo J, et al. Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol Lett. 2010;199(3):389-397.
23. Moos PJ, Chung K, Woessner D, Honeggar M, Cutler NS, Veranth JM. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem Res Toxicol. 2010;23(4):733-739.
24. Sasidharan A, Chandran P, Menon D, Raman S, Nair S, Koyakutty M. Rapid dissolution of ZnO nanocrystals in acidic cancer microenvironment leading to preferential apoptosis. Nanoscale. 2011;3(9):3657-3669.
25. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis. 2012;17(8): 852-870.
26. Di Gioacchino M, Petrarca C, Lazzarin F, et al. Immunotoxicity of nanoparticles. Int J Immunopathol Pharmacol. 2011;24 Suppl 1: S65-S71.
27. Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol. 2010;7:22.
28. Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29(1):69-78.
29. Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles - an antimicrobial study. Sci Tech Adv Mater. 2008;9(3): 035004.
30. Dwivedi PD, Misra A, Shanker R, Das M. Are nanomaterials a threat to the immune system? Nanotoxicology. 2009;3(1):19-26.
31. Kim K-M, Kim T-H, Kim H-M, et al. Colloidal behaviors of ZnO nanoparticles in various aqueous media. Toxicol Environ Health Sci. 2012;4(2):121-131.
32. Yeh TK, Chen JK, Lin CH, et al. Kinetics and tissue distribution of neutron-activated zinc oxide nanoparticles and zinc nitrate in mice: effects of size and particulate nature. Nanotechnology. 2012;23(8):085102.
33. Cho WS, Duffin R, Howie SE, et al. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 2011;8:27.
34. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010;4(1):15-29.
35. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2(10): 2121-2134.
36. Feltis BN, O’Keefe SJ, Harford AJ, et al. Independent cytotoxic and inflammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotoxicology. 2012;6(7):757-765.
37. Baek M, Kim MK, Cho HJ, et al. Factors influencing the cytotoxicity of zinc oxide nanoparticles: particle size and surface charge. J Phys Conf Ser. 2011;304(1):012044.
38. Horie M, Fujita K, Kato H, et al. Association of the physical and chemical properties and the cytotoxicity of metal oxide nanoparticles: metal ion release, adsorption ability and specific surface area. Metallomics. 2012;4:350-360.
39. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradtion. Biochim Biophys Acta. 2011;1810(3):361-373.
40. Plascencia-Villa G, Starr CR, Armstrong LS, Ponce A, Yacaman MJ. Imaging interactions of metal oxide nanoparticles with macrophage cells by ultra-high resolution scanning electron microscopy techniques. Integr Biol. 2012;4:1358-1366.
41. Hanna J, Mandelboim O. When killers become helpers. Trends Immunol. 2007;28:201-206.
42. 2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol. 2012;264(1):94-103.
43. Lowe DB, Shearer MH, Jumper CA, Bright RK, Kennedy RC. Fc gamma receptors play a dominant role in protective tumor immunity against a virus encoded tumor-specific antigen in a murine model of experimental metastases. J Virol. 2007;81(3):1313-1318.
44. Green SJ, Scheller LF, Marletta MA, et al. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett. 1994;43(1-2):87-94.
45. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 2003;54(4):469-487.
46. Holan V, Krulova M, Zajicova A, Pindjakova J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol. 2002;38(12-13):989-995.
47. Marcinkiewicz J, Chain BM. Differential regulation of cytokine production by nitric oxide. Immunology. 1993;80(1):146-150.
48. Schwentker A, Vodovotz Y, Weller R, Billiar TR. Nitric oxide and wound repair: role of cytokines? Nitric Oxide. 2002;7(1):1-10.
49. Tavares Murta BM, Machado JS, Zaparoli M, Lara VC, Murta EF. The relationship of host immune cells, cytokine and nitric oxide production to tumor cells in ovarian carcinoma. Sao Paulo Med J. 1999;117(2):87-92.